Medline Inc (MDLN) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 27 2026 to Mar 29 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Medline Inc   (NASDAQ: MDLN)


Medline Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Medline Inc's ROI in the second quarter of 2026?
Medline Inc achieved a return on average invested assets (ROI) of 1.83 % in its second quarter of 2026, this is above MDLN's average return on investment of 0%.
Medline Inc s investments during the 12 months ending in the second quarter of 2026 are valued at $45 billion

ROI decreased relative to the period ending Mar 28 2026, due to the decline in net income.

Within the Healthcare sector Medline Inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 27 2026)
II. Quarter		 (Mar 28 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Jun 28 2025)
II. Quarter		 (Mar 29 2025)
I. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM -95.03 % - - - -
Investment (TTM) in Millions 44,145 44,555 44,543 49,363 0
Return On Investment (TTM) 1.83 % 50.57 % 73 % 138.87 % -
MDLN's Overall Ranking # # # # #
Seq. Investment Change TTM 31.88 % 47.45 % 90.24 % - -
Seq. Net Income Change TTM -95.22 % 2.15 % 0 % 1.96 % -
Net Income (TTM) in Millions 836 17,506 17,138 17,138 16,809

MDLN Company Profile >> Back to MDLN Roi Comparisons >> See Annual MDLN Return On Investment



Return On Investment MDLN's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Medline Inc's II. Quarter Investments $ 44,145 Millions MDLN's Balance sheet
Medline Inc's II. Quarter Income $ 139 Millions Quarterly MDLN's Income Statement
MDLN's Income by Division See MDLN's Income by Division


MDLN Annual Return On Investment (Dec 31 2025)
2025



Total Investments in Millions 41,001 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 1,161 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 2.83 % - - - -


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 2.83 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MDLN's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MDLN's Competitors
Subscribers only: Roi for Medline Inc's Suppliers
Subscribers only: Return On Investment for MDLN's Customers

Other Ratios
MDLN's Roa MDLN's Inventory Turnover Ratio MDLN's Growth Rates MDLN's Dividend Statistics
MDLN's Profitability Ratios MDLN's Asset Turnover Ratio MDLN's Dividend Growth
MDLN's Roe MDLN's Valuation Ratios MDLN's Financial Strength Ratios MDLN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 27 2026, within Healthcare Sector ROI
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %
Atricure Inc   1.84 %
Black Hawk Acquisition Corporation  1.79 %
Omada Health Inc   1.70 %
Arvinas Inc   1.53 %
Repligen Corp  1.41 %

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.